Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Hypericum perforatum aerial extract is a botanical preparation derived from the flowering tops, leaves, and stems of the St. John's Wort plant (*Hypericum perforatum* L.). It contains a complex mixture of active constituents, most notably hyperforin, hypericin, and various flavonoids like quercetin and rutin. Historically used for mild to moderate depression, its primary mechanism of action involves the non-selective inhibition of the reuptake of serotonin, norepinephrine, and dopamine. Beyond its psychiatric applications, recent research has highlighted its potential in managing hepatic oxidative stress and cytoprotection in metabolic disorders like diabetes by modulating pathways involving CYP2E1 and PARP. It is widely available as both a regulated herbal medicinal product and a dietary supplement.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on hypericum perforatum aerial extract.